10-Q: Health Catalyst Reports First Quarter 2024 Results, Revenue Stable Amidst Strategic Shifts

Health Catalyst's first quarter 2024 results show stable revenue with a net loss, as the company navigates a challenging macroeconomic environment and strategic transitions.

Summary

• Health Catalyst reported total revenue of $74.7 million for the first quarter of 2024, a slight increase from $73.9 million in the same period last year.
• The company experienced a net loss of $20.6 million for the quarter, an improvement compared to a $33.2 million loss in the first quarter of 2023.
• Adjusted EBITDA was $3.4 million, down from $4.2 million in the prior year's first quarter.
• Technology revenue was $47.0 million, while professional services revenue was $27.8 million.
• The company is migrating clients to its new Health Catalyst Ignite platform, which is expected to provide a technology gross margin tailwind in the medium term but a near-term headwind.
• The company is also seeing a higher proportion of bookings from its professional services offering, particularly Tech-enabled Managed Services (TEMS), which has a lower initial gross margin but is expected to improve over time.
• The company's strategic operating plan emphasizes offerings with the most competitive differentiation and measurable financial and operational ROI.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While there are positive signs like improved net loss and strategic shifts, the decrease in Adjusted EBITDA and the challenges in the macroeconomic environment temper the overall outlook. The company is navigating a complex situation, and the future is uncertain.

Positives

• The net loss improved significantly year-over-year, decreasing from $33.2 million to $20.6 million.
• The company is actively migrating clients to the Health Catalyst Ignite platform, which is expected to improve technology gross margin in the medium term.
• The company is focusing on offerings with the most competitive differentiation and measurable financial and operational ROI.
• The company's strategic operating plan is proactively responding to the macroeconomic environment.

Negatives

• Adjusted EBITDA decreased year-over-year, from $4.2 million to $3.4 million.
• The migration to Health Catalyst Ignite is expected to create a near-term headwind.
• The shift towards professional services, particularly TEMS, is expected to lower gross margins in the near term.
• The company is experiencing elevated churn levels, primarily for offerings that do not provide a near-term measurable financial ROI.

Risks

• The challenging macroeconomic environment, including high inflation and interest rates, continues to impact the healthcare industry and the company's clients.
• The company faces intense competition from various players in the healthcare technology and services market.
• The company's ability to manage growth, organizational changes, and cost reduction initiatives is critical to its future performance.
• The company's reliance on third-party providers for computing infrastructure and data sourcing poses risks to its operations.
• The company is subject to various healthcare and data privacy regulations, and any failure to comply could result in penalties and harm its business.
• The company's reliance on a limited number of large clients for a significant portion of its revenue creates a risk of financial instability if those clients are lost or renegotiate their contracts.
• The company's convertible senior notes due in 2025 require significant cash for servicing and repayment, and the company may not have sufficient funds or the ability to raise the necessary capital.

Future Outlook

The company anticipates improvement in bookings metrics relative to 2022 and 2023, and expects aggregate churn levels in 2024 to improve compared to 2023. The company expects to migrate existing DOS Subscription Clients to the new Health Catalyst Ignite platform over the next two to three years. The company anticipates that adjusted operating expenses as a percentage of revenue will trend lower, largely due to restructuring efforts and continued operating leverage.

Management Comments

• The company is proactively responding to the macroeconomic environment with a strategic operating plan.
• The company is making investments in research and development, primarily in enhancing the capabilities within Health Catalyst Ignite.
• The company believes its focus will enable it to move forward in a position of continued competitive and financial strength.

Industry Context

The healthcare industry is experiencing significant financial strain due to increased labor and supply costs, which is impacting the demand for technology and services. Health Catalyst is adapting to these challenges by focusing on solutions that provide a near-term financial return on investment for clients.

Comparison to Industry Standards

• The company's revenue growth is modest compared to some high-growth SaaS companies, but it is stable in a challenging market.
• The company's net loss is improving, which is a positive sign compared to some other companies in the healthcare technology sector that are still struggling with profitability.
• The company's focus on TEMS is a strategic move to address the immediate needs of healthcare systems, which is a common trend in the industry.
• The migration to a new platform is a significant undertaking, similar to what other companies in the industry are doing to modernize their technology.
• The company's adjusted gross margin is relatively high compared to some other companies in the professional services sector, but it is expected to decline in the near term due to the shift towards TEMS.

Management Changes

Corporate Governance

Legal Proceedings

• The company was party to a legal proceeding with Pascal Metrics, Inc. that was settled on June 15, 2023, with a payment of $18.8 million and a broad intellectual property license.

Related Party Transactions

• The company recognized revenue from a related party of $4.1 million for the three months ended March 31, 2024.

Stakeholder Impact

• Shareholders may experience volatility in the stock price due to market conditions and the company's performance.
• Employees may be affected by restructuring activities and changes in compensation programs.
• Clients may experience changes in service delivery and pricing as the company transitions to new platforms and offerings.
• Suppliers may be impacted by changes in the company's procurement policies and spending.

Next Steps

• The company will continue to refine its strategic operating plan.
• The company will continue to make investments in research and development, primarily in enhancing the capabilities within Health Catalyst Ignite.
• The company will continue to migrate existing DOS Subscription Clients to the new Health Catalyst Ignite platform over the next two to three years.

Key Dates

Keywords

healthcare analytics, data platform, professional services, technology subscriptions, Health Catalyst Ignite, Adjusted EBITDA, revenue, net loss, macroeconomic challenges, client migration, Tech-enabled Managed Services, TEMS, gross margin